KeyCorp Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $5.00
Health Catalyst (NASDAQ:HCAT – Free Report) had its price target lowered by KeyCorp from $7.00 to $5.00 in a report published on Wednesday, Marketbeat reports. The firm currently has an overweight rating on the stock. Other equities analysts also recently issued research reports about the stock. Evercore ISI downgraded shares of Health Catalyst from an […]
Health Catalyst (NASDAQ:HCAT – Free Report) had its price target lowered by KeyCorp from $7.00 to $5.00 in a report published on Wednesday, Marketbeat reports. The firm currently has an overweight rating on the stock. Other equities analysts also recently issued research reports about the stock. Evercore ISI downgraded shares of Health Catalyst from an […]